Monash spearheads breakthrough in heart health with innovative device suite

By Our Reporter

Monash University is set to spearhead a transformative initiative aimed at revolutionising the treatment of heart failure through the development and commercialisation of groundbreaking implantable cardiac devices. With a generous $50 million grant from the Medical Research Future Fund (MRFF), the university will lead a diverse consortium in the Artificial Heart Frontiers Program. This ambitious project, stationed at the Monash Alfred Baker Centre for Cardiovascular Research at The Alfred, is poised to develop three pioneering devices that promise to extend and enhance the lives of those suffering from all forms of debilitating heart failure.

The Hon Mark Butler, Minister for Health and Aged Care, has endorsed this initiative, highlighting its potential to halve heart failure mortality rates and position Australia as a global frontrunner in cardiac medical technology, from clinical trials to local manufacturing. The suite of devices includes the Mini-Pump, a novel miniature device implanted directly in the heart; a new Left Ventricle Assist Device (LVAD) that aids the heart’s pumping action; and the BiVACOR Total Artificial Heart (TAH), a complete heart replacement developed in collaboration between Australia and the US.

These devices stand out for their ability to automatically adjust to the body’s physical demands, a feature that marks a significant advance over current technologies with fixed blood flow rates that limit patient activity. This innovation offers a beacon of hope for heart failure patients, enabling them to lead more active lives without the constraint of breathlessness.

Monash University’s Vice-Chancellor, Professor Sharon Pickering, emphasizes the project’s alignment with the university’s commitment to impactful research and innovation. This MRFF grant not only acknowledges Monash’s global leadership in cardiac and engineering research but also its dedication to collaborative efforts that address worldwide challenges.

The project is expected to yield profound societal and economic benefits by 2036, including a $1.8 billion boost to Australia, savings in healthcare costs, job creation, and early access to emerging technologies for Australian patients.

Professor David Kaye, project co-lead and Director of Cardiology at The Alfred, and Professor Shaun Gregory, co-lead from Monash University’s Faculty of Engineering, underscore the devices’ potential to drastically improve the quality of life for heart failure patients. By mimicking a natural heart’s response, these devices will allow patients to undertake daily activities without the limitations of their condition.

The initiative also promises to lay the foundation for a new medical device industry in Australia, fostering advancements in engineering, clinical evaluation, and translational research within the health sector. Dr Daniel Timms, BiVACOR founder and TAH designer, celebrates the consortium as a milestone in innovation and industry development, supported by Australia’s leading research institutions.

Monash University’s commitment to cardiovascular health research continues to shape global understanding and treatment of heart disease, underlining the university’s role in advancing healthcare both in Australia and internationally.

Support independent community journalism. Support The Indian Sun.

Follow The Indian Sun on Twitter | InstagramFacebook


Donate To The Indian Sun

Dear Reader,

The Indian Sun is an independent organisation committed to community journalism. We have, through the years, been able to reach a wide audience especially with the growth of social media, where we also have a strong presence. With platforms such as YouTube videos, we have been able to engage in different forms of storytelling. However, the past few years, like many media organisations around the world, it has not been an easy path. We have a greater challenge. We believe community journalism is very important for a multicultural country like Australia. We’re not able to do everything, but we aim for some of the most interesting stories and journalism of quality. We call upon readers like you to support us and make any contribution. Do make a DONATION NOW so we can continue with the volume and quality journalism that we are able to practice.

Thank you for your support.

Best wishes,
Team The Indian Sun